367 related articles for article (PubMed ID: 22471524)
61. Expenditures for psychotropic medications in the United States in 1985.
Zorc JJ; Larson DB; Lyons JS; Beardsley RS
Am J Psychiatry; 1991 May; 148(5):644-7. PubMed ID: 2018168
[TBL] [Abstract][Full Text] [Related]
62. Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study.
Croteau C; Mottron L; Dorais M; Tarride JE; Perreault S
Autism; 2019 Nov; 23(8):2020-2030. PubMed ID: 30943759
[TBL] [Abstract][Full Text] [Related]
63. Asthma-related healthcare services utilization by African-Americans enrolled in West Virginia Medicaid.
Pawar V; Smith MJ
Respir Med; 2006 Sep; 100(9):1579-87. PubMed ID: 16495039
[TBL] [Abstract][Full Text] [Related]
64. Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state.
Essock SM; Covell NH; Leckman-Westin E; Lieberman JA; Sederer LI; Kealey E; Finnerty MT
Psychiatr Serv; 2009 Dec; 60(12):1595-602. PubMed ID: 19952148
[TBL] [Abstract][Full Text] [Related]
65. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
[TBL] [Abstract][Full Text] [Related]
66. Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children.
Kreider AR; Matone M; Bellonci C; dosReis S; Feudtner C; Huang YS; Localio R; Rubin DM
J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):960-970.e2. PubMed ID: 25151419
[TBL] [Abstract][Full Text] [Related]
67. Medicaid Expenditures for Fee-for-Service Enrollees with Behavioral Diagnoses: Findings from a 50 State Claims Analysis.
Ward MC; Lally C; Druss BG
Community Ment Health J; 2017 Jan; 53(1):1-7. PubMed ID: 27306989
[TBL] [Abstract][Full Text] [Related]
68. Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014.
Lopez-Leon S; Lopez-Gomez MI; Warner B; Ruiter-Lopez L
Daru; 2018 Sep; 26(1):5-10. PubMed ID: 30159759
[TBL] [Abstract][Full Text] [Related]
69. Medication adherence among recipients with chronic diseases enrolled in a state Medicaid program.
Khanna R; Pace PF; Mahabaleshwarkar R; Basak RS; Datar M; Banahan BF
Popul Health Manag; 2012 Oct; 15(5):253-60. PubMed ID: 22401152
[TBL] [Abstract][Full Text] [Related]
70. Use of psychotropic medications in São Paulo Metropolitan Area, Brazil: pattern of healthcare provision to general population.
Campanha AM; Siu ER; Milhorança IA; Viana MC; Wang YP; Andrade LH
Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1207-14. PubMed ID: 26154976
[TBL] [Abstract][Full Text] [Related]
71. Prescribing of psychotropic medications to patients without a psychiatric diagnosis.
Wiechers IR; Leslie DL; Rosenheck RA
Psychiatr Serv; 2013 Dec; 64(12):1243-8. PubMed ID: 23999894
[TBL] [Abstract][Full Text] [Related]
72. Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population.
Harley C; Li H; Corey-Lisle P; L'Italien GJ; Carson W
Soc Psychiatry Psychiatr Epidemiol; 2007 Sep; 42(9):690-7. PubMed ID: 17603740
[TBL] [Abstract][Full Text] [Related]
73. Mental disorders and service use among welfare and disability program participants in fee-for-service Medicaid.
Pavetti L; Derr MK; Kauff JF; Barrett A
Psychiatr Serv; 2010 May; 61(5):495-9. PubMed ID: 20439371
[TBL] [Abstract][Full Text] [Related]
74. Health care expenditures for children with autism spectrum disorders in Medicaid.
Wang L; Leslie DL
J Am Acad Child Adolesc Psychiatry; 2010 Nov; 49(11):1165-71. PubMed ID: 20970704
[TBL] [Abstract][Full Text] [Related]
75. Medicaid spending and utilization for central nervous system drugs.
Baugh DK; Pine PL; Blackwell S; Ciborowski G
Health Care Financ Rev; 2004; 26(1):57-73. PubMed ID: 15776700
[TBL] [Abstract][Full Text] [Related]
76. Prevalence of psychotropic use in a South Australian population.
Goldney R; Bain M
Australas Psychiatry; 2006 Dec; 14(4):379-83. PubMed ID: 17116076
[TBL] [Abstract][Full Text] [Related]
77. Trends in the use of psychotropic drugs in Taiwan: a population-based national health insurance study, 1997-2004.
Chien IC; Bih SH; Chou YJ; Lin CH; Lee WG; Chou P
Psychiatr Serv; 2007 Apr; 58(4):554-7. PubMed ID: 17412860
[TBL] [Abstract][Full Text] [Related]
78. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
[TBL] [Abstract][Full Text] [Related]
79. Increased risk among older veterans of prescribing psychotropic medication in the absence of psychiatric diagnoses.
Wiechers IR; Kirwin PD; Rosenheck RA
Am J Geriatr Psychiatry; 2014 Jun; 22(6):531-9. PubMed ID: 24211029
[TBL] [Abstract][Full Text] [Related]
80. Utilization of psychotropic drugs prescribed to persons with and without HIV infection: a Danish nationwide population-based cohort study.
Rasmussen LD; Obel D; Kronborg G; Larsen CS; Pedersen C; Gerstoft J; Obel N
HIV Med; 2014 Sep; 15(8):458-69. PubMed ID: 24589241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
